The board of directors of China Resources Medical Holdings Company Limited announced that Mr. HU Hui (Mr. HU) has resigned, with effect from September 14, 2023, as a non-executive Director and a member of the audit committee of the Company (Audit Committee) due to changes in internal work arrangement of China Resources Healthcare Group Limited (CR Health), the controlling shareholder of the Company. Mr. HU has confirmed that he has no disagreement with the Board and that there is no matter in respect of his resignations which needs to be brought to the attention of the shareholders of the Company (the Shareholder(s)) and The Stock Exchange of Hong Kong Limited (the Stock Exchange). The Board announced that Ms. GE Lu (Ms. GE) has been appointed as a non-executive Director with effect from September 14, 2023. Ms. GE, aged 52, was appointed as an external director of CR Health in August 2021. She is also a designated external director of the business unit(s) of China Resources Group. Ms. GE served as positions including the vice general manager, chief information officer of China Resources Pharmaceutical Commercial Group Limited and China Resources Pharmaceutical Group Limited and the general manager assistant of Beijing Pharmaceutical Co. Ltd. (now known as China Resources Pharmaceutical Commercial Group Limited ()) from January 2010 to August 2021. Ms. GE has over 30 years of working experience in the pharmaceutical industry and specializes in supply chain management, logistics management and information systems management and planning in the pharmaceutical distribution field. Ms. GE holds a master's degree of business administration from Tsinghua University and a bachelor's degree of
computer science from Beijing Jiaotong University, and holds the title of Senior Engineer. The Board announced that Mr. ZHOU Peng (Mr. ZHOU) has been appointed as an independent non-executive Director with effect from September 14, 2023. Mr. ZHOU, aged 46, is the founder of Deep Blue Ridge Capital (DBR Capital). DBR Capital is a multi-strategy investment firm based in Hong Kong. Mr. ZHOU has 20 years of experience in global mergers and acquisitions and capital markets. Before founding DBR Capital, Mr. Zhou worked in Deutsche Bank (Hong Kong) and Credit Suisse (New York), and cooperated with the world's top institutional and corporate clients to complete a number of cross-industry and cross-product transactions; and Mr. ZHOU's career began in Bank of China. Mr. ZHOU holds a master's degree in business administration from Columbia University in New York. The Board announces that Mr. KWONG Kwok Kong has resigned as a member of the Remuneration Committee; Ms. GE has been appointed as a member of the Remuneration Committee; and Mr. ZHOU has been appointed as a member of the Audit Committee with effect from September 14, 2023.